Page last updated: 2024-09-05

dofequidar and Neoplasm Metastasis

dofequidar has been researched along with Neoplasm Metastasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hanibuchi, M; Higasida, T; Nishioka, Y; Nokihara, H; Sone, S; Tsuruo, T; Yano, S	1

Other Studies

1 other study(ies) available for dofequidar and Neoplasm Metastasis

Article	Year
A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells. Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:7 Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Neoplasm Metastasis; Quinolines; Vincristine; Xenograft Model Antitumor Assays	2001

Article

Year

A new quinoline derivative MS-209 reverses multidrug resistance and inhibits multiorgan metastases by P-glycoprotein-expressing human small cell lung cancer cells.

Japanese journal of cancer research : Gann, 2001, Volume: 92, Issue:7

Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Doxorubicin; Drug Resistance, Multiple; Drug Screening Assays, Antitumor; Etoposide; Humans; Lung Neoplasms; Male; Mice; Mice, SCID; Neoplasm Metastasis; Quinolines; Vincristine; Xenograft Model Antitumor Assays

2001